References
- Ballenger J. C., Post R. M. Carbamazepine in manic depressive illness: a new treatment. American Journal of Psychiatry 1980; 137: 782–90
- Birkhimer L. J., Curtis J. L., Jann M. W. Use of carbamazepine in psychiatric disorders. Clinical Pharmacy 1985; 4: 425–34
- Chaudry R. P., Waters B. G. H. Lithium and carbamazepine interaction: possible neurotoxicity. Journal of Clinical Psychiatry 1983; 44: 31–2
- Jann M. W., Ereshefsky L., Saklad S. R., et al. Effects of carbamazepine on plasma haloperidol levels. Journal of Clinical Psychopharmacology 1985; 5: 106–9
- Kanter G. L., Yerevanian B. I., Ciccone R. Case report of a possible interaction between neuroleptics and carbamazepine. American Journal of Psychiatry 1984; 141: 1101–2
- Okuma T. Therapeutic and prophylactic effects of carbamazepine in bipolar disorder. Psychiatric Clinics of North America 1983; 6: 157–74
- Reynolds E. H. Neurotoxicity of carbamazepine. Advances in Neurology, J. K. Penny, D. D. Dalby. Raven Press, New York 1975; 343–53
- Shukla S., Godwin C. D., Long L. E. B., Miller M. G. Lithium-carbamazepine neurotoxicity and risk factors. American Journal of Psychiatry 1984; 141: 1604–6
- Wraae O. The pharmacokinetics of lithium in the brain, cerebrospinal fluid and serum of the rat. British Journal of Pharmacology 1978; 64: 273–9
- Yerevanian B. I., Hodgeman C. H. A haloperidol carbamazepine interaction in a patient with rapid-cycling disorder (letter). American Journal of Psychiatry 1985; 142: 785–6